Skip to content

Early detection of dementia using brain perfusion SPECT with cognitive stress test

Early detection of dementia using brain perfusion SPECT with cognitive stress test

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190811001
Enrollment
155
Registered
2019-08-11
Start date
2019-08-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment (MCI) mild cognitive impairment early detection dementia screening brain imaging cognitive stress perfusion SPECT

Interventions

LASSI&#45
L is a neuropsychological test use for cognitive stress to stimulate brain perfusion in SPECT study. It will be applied to all subjects.
Experimental Behavioral

Sponsors

Ratchadapiseksompotch Grant, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Age 55 - 85 years - No known history of uncontrolled psychiatric disease - Stable controllable dementia without choline esterase inhibitor adjustment in the past 3 months - Thai nationality

Exclusion criteria

Exclusion criteria: - Diseases which affect this study eg.chronic kidney disease (GFR=7mg% ), all types of cancer - Who cannot perform CT or MRI of the brain - Those who have dementia etiology from other causes eg. depression, cerebrovascular disease, etc. - Patients with neurological disease that affects cognition eg. epilepsy, parkinson disease etc. - Those who cannot read/write/speak Thai language. - Those who have MRI finding of frank cerebrovascular disease - Those who have abnormal lab tests: CBC, Bun, Cr, Electrolytes, LFT, metabolic blood test (Thyroid Function Test, folate, B12, lipid profile, FBS, HbA1c), inflammation/infection blood tests (Syphilis, HIV, ESR) - Mild dementia patients with abnormal special blood test (autoimmune/paraneoplastic panel, antineuronal IgG, anti-TPO, anti-thyroglobulin)

Design outcomes

Primary

MeasureTime frame
Alzheimer's dementia at 3 years after detection of mild cognitive impairment & SPECT Brain perfusion SPECT

Secondary

MeasureTime frame
MMSE and MoCA score at 3 years MMSE and MoCA neurophyschological tests

Countries

Thailand

Contacts

Public ContactSupatporn Tepmongkol

Chualongkorn University

supatporn@hotmail.com0817743767

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026